Tuberculosis :: Eli Lilly invests $50 million for MDR tuberculosis
Eli Lilly and Company announced plans to invest an additional $50 million in an innovative, global partnership to fight Multi-Drug Resistant Tuberculosis (MDR-TB). The announcement is being made in conjunction with World TB Day activities.